Covidien deals Stellarex balloon to Spectranetics for $30m

Covidien agrees to deal its Stellarex drug-coated balloon to Spectranetics for $30 million is it looks to satisfy U.S. anti-trust regulators ahead of a $43 billion merger with Medtronic.

Covidien, Medtronic, Spectranetics Corp.

News Well, Medtronic buys Covidien, Mergers & Acquisitions, Peripheral Artery Disease

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1x13KBe